Critical evaluation of the variants influencing the clinical response of vitiligo: Study of 60 cases treated with ultraviolet B narrow-band phototherapy

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 10, 2007, Pages 1369-1374

  Brazzelli, V ^a   Antoninetti, M ^a   Palazzini, S ^a   Barbagallo, T ^a   de Silvestri, A ^a   Borroni, G ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Body sites; Clinical response; UVB NB phototherapy; Vitiligo

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY REGIONS; CHILD; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PHOTOTHERAPY; PRIORITY JOURNAL; SKIN PIGMENTATION; TREATMENT DURATION; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION; VITILIGO;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHI-SQUARE DISTRIBUTION; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; SKIN PIGMENTATION; TIME FACTORS; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITILIGO;

EID: 35649018189     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02278.x     Document Type: Article

References (23)

1. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998; 38: 647-666.
2. Handa S, Kaur I. Vitiligo: Clinical findings in 1436 patients. J Dermatol 1999; 26: 653-657.
3. Halder RM. Childhood vitiligo. Clin Dermatol 1997; 15: 899-906.
4. Njoo MD, Westerhof W. Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol 2001; 2: 167-181.
5. Mosher DB, Fitzpatrick TB, Ortonne JB. Abnormalities of pigmentation. In: Fitzpatric TB, Eisen AZ, Wolff K et al., eds. Dermatology in General Medicine. McGraw-Hill, New York, 1979: 582-590.
6. Palermo B, Campanelli R, Garbelli S et al. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex peptide tetramers: The role of cellular immunity in the etiopathogenesis of vitiligo. J Invest Dermatol 2001; 17: 326-332.
7. Scherschun L, Kim JJ, Lim HV. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44: 999-1003.
8. Ortonne JP, Fitzpatrick TB. Normal skin colour and general considerations of pigmentary disorders. In: Freedberg IM, Eisen AZ, Wolff K et al., eds. Dermatology in General Medicine, 6th edn. McGraw-Hill, New York, 2003: 819-826.
9. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-253.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
11. Nordlund JJ, Halder RM, Grimes P. Management of vitiligo. Dermatol Clin 1993; 11: 27-33.
12. Westerhof W, Nieuweboer-Krobtova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997; 133 (12): 1525-1528.
13. Njoo MD, Westerhof W, Bos JD, Bossuyt PM. The development of guidelines for the treatment of vitiligo. Arch Dermatol 1999; 135: 1514-1521.
14. Kanwar AJ, Dogra S, Parsad D, Kumar B. Narrow-band UVB for the treatment of vitiligo: An emerging effective and well-tolerated therapy. Int J Dermatol 2005; 44: 57-60.
15. Kanvar AJ, Droga S. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin Exp Dermatol 2005; 30: 332-336.
16. Norris DA, Horikawa T, Morelli JG. Melanocyte destruction and repopulation in vitiligo. Pigment Cell Res 1994; 7: 193-203.
17. Fitzpatrick TB. Mechanisms of phototherapy in vitiligo. Arch Dermatol 1997; 133: 1591-1592.
18. Cui J, Shen LY, Wang GC. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 1991; 97: 410-416.
19. Imokawa G, Miyagishi M, Yada Y. Endothelin-1 as a new melanogen: coordinated expression of this gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol 1995; 105: 32-37.
20. Natta R, Somsak T, Wisuttida T, Laor L. Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians. J Am Acad Dermatol 2003; 49: 473-476.
21. Brazzelli V, Prestinari F, Castello M et al. Useful treatment of vitiligo in 10 children with UVB narrowband (311 nm). Pediatr Dermatol 2005; 22: 257-261.
22. Brazzelli V, Prestinari F, Barbagallo T, Bellani E, Borroni G. Long-term narrowband UVB phototherapy in vitiligo: Good results are correlated with a long period of continuous and constant therapy. G Ital Dermatol Venereol 2004; 139: 171-179.
23. Anbar TS, Westerhof W, Abdel-Rahman El-Khayyat MA. Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites. Photodermatol Photoimmunol Photomed 2006; 22: 157-163.